Bispectral Index Monitoring To Guide Sedation In The Critical Care Setting
Launched by HOSPITAL UNIVERSITARI DE BELLVITGE · Sep 19, 2016
Trial Information
Current as of May 13, 2025
Unknown status
Keywords
ClinConnect Summary
Patients admitted to the intensive care unit (ICU) usually require use of hypnotics and sedatives to ensure comfort and proper adaptation to mechanical ventilation. An important requirement for an adequate sedation is frequent and proper assessment of its depth. Inadequate sedation can lead to problems of over-sedation, under-sedation and/or delirium in ICU, especially in elderly patients. The main objective od the study is To compare the total dose of sedative use and the rate of over-sedation in patients over 65 years admitted to the ICU, adjusting sedation by monitoring with BIS® versus ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over 65 yers
- • Patients admitted to teintensive care unit of the University Hospital of Bellvitge medical or surgical pathology of neurological etiology
- • Patiens requiring sedation for more than 24 hours
- Exclusion Criteria:
- • Patients less than 65 years
- • Patients admitted to the ICU with Neurological condition.
- • Postoperative patients admitted and extubation is expected within 24 hours.
About Hospital Universitari De Bellvitge
Hospital Universitari de Bellvitge is a leading academic medical center located in L'Hospitalet de Llobregat, Spain, affiliated with the University of Barcelona. Renowned for its commitment to advanced patient care, innovative research, and education, the hospital plays a pivotal role in the development and execution of clinical trials across various therapeutic areas. With a multidisciplinary team of healthcare professionals and researchers, Hospital Universitari de Bellvitge strives to enhance medical knowledge and improve treatment outcomes through rigorous scientific inquiry and collaboration. Its state-of-the-art facilities and comprehensive patient care services make it an ideal environment for conducting high-quality clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Luisa Corral, MD
Study Director
Barcelona University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials